[144] Mirum Pharmaceuticals, Inc. SEC Filing
Mirum Pharmaceuticals, Inc. (MIRM) filed a Form 144 reporting the proposed sale of 40,000 common shares acquired by stock option exercise on 08/11/2025. The sale is to be executed through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,480,000 based on the filing and the company has 50,237,647 shares outstanding as shown.
The filing also records a prior sale during the past three months: Christopher Peetz sold 40,000 shares on 08/07/2025 for $2,210,040. The filer certifies they have no undisclosed material adverse information and notes the securities were paid for in cash at acquisition.
Mirum Pharmaceuticals, Inc. (MIRM) ha depositato un Form 144 segnalando la proposta vendita di 40,000 azioni ordinarie acquisite mediante esercizio di opzioni su azioni il 08/11/2025. La vendita sar脿 eseguita tramite Morgan Stanley Smith Barney LLC con un valore di mercato complessivo di $2,480,000 secondo il deposito, e la societ脿 risulta avere 50,237,647 azioni in circolazione, come indicato.
Il deposito riporta anche una vendita precedente negli ultimi tre mesi: Christopher Peetz ha venduto 40,000 azioni il 08/07/2025 per $2,210,040. Il dichiarante certifica di non possedere informazioni materiali sfavorevoli non divulgate e specifica che i titoli sono stati pagati in contanti al momento dell'acquisizione.
Mirum Pharmaceuticals, Inc. (MIRM) present贸 un Form 144 informando la propuesta de venta de 40,000 acciones ordinarias adquiridas mediante ejercicio de opciones sobre acciones el 08/11/2025. La venta se realizar谩 a trav茅s de Morgan Stanley Smith Barney LLC con un valor de mercado agregado de $2,480,000 seg煤n la presentaci贸n, y la compa帽铆a tiene 50,237,647 acciones en circulaci贸n, como se indica.
La presentaci贸n tambi茅n registra una venta previa durante los 煤ltimos tres meses: Christopher Peetz 惫别苍诲颈贸 40,000 acciones el 08/07/2025 por $2,210,040. El declarante certifica que no posee informaci贸n adversa material no divulgada y se帽ala que los valores fueron pagados en efectivo en el momento de la adquisici贸n.
Mirum Pharmaceuticals, Inc. (MIRM)电� Form 144毳� 鞝滌稖頃橃棳 08/11/2025鞐� 欤检嫕毵れ垬靹犿儩甓� 頄夓偓搿� 旆摑頃� 40,000 氤错喌欤�鞚� 毵る弰毳� 鞝滌晥頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 毵る弰电� Morgan Stanley Smith Barney LLC毳� 韱淀暣 鞁ろ枆霅� 鞓堨爼鞚措┌, 鞝滌稖靹滌棎 霐半ゴ氅� 齑� 鞁滌灔臧�旃� $2,480,000鞚搓碃 須岇偓鞚� 氚滍枆欤检嫕靾樀鐢 50,237,647欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 鞝滌稖靹滌棎电� 歆�雮� 3臧滌洈 霃欖晥鞚� 鞚挫爠 毵る弰霃� 旮办灛霅橃柎 鞛堨姷雼堧嫟: Christopher Peetz电� 08/07/2025鞐� 40,000欤�毳� $2,210,040鞐� 毵る弰頄堨姷雼堧嫟. 鞝滌稖鞛惖鐢 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃橂┌, 旆摑 鞁� 歃濌秾鞚� 顺勱笀鞙茧 歆�旮夒悩鞐堧嫟瓿� 氇呾嫓頄堨姷雼堧嫟.
Mirum Pharmaceuticals, Inc. (MIRM) a d茅pos茅 un Form 144 signalant la proposition de vente de 40,000 actions ordinaires acquises par exercice d'options sur actions le 08/11/2025. La vente doit 锚tre ex茅cut茅e par Morgan Stanley Smith Barney LLC pour un valeur de march茅 agr茅g茅e de $2,480,000 d'apr猫s le d茅p么t, et la soci茅t茅 compte 50,237,647 actions en circulation, comme indiqu茅.
Le d茅p么t enregistre 茅galement une vente ant茅rieure au cours des trois derniers mois : Christopher Peetz a vendu 40,000 actions le 08/07/2025 pour $2,210,040. Le d茅clarant certifie qu'il ne dispose d'aucune information d茅favorable mat茅rielle non divulgu茅e et pr茅cise que les titres ont 茅t茅 pay茅s en 别蝉辫猫肠别蝉 lors de l'acquisition.
Mirum Pharmaceuticals, Inc. (MIRM) hat ein Form 144 eingereicht, in dem der geplante Verkauf von 40.000 Stammaktien gemeldet wird, die durch Aus眉bung von Aktienoptionen am 08/11/2025 erworben wurden. Der Verkauf soll 眉ber Morgan Stanley Smith Barney LLC ausgef眉hrt werden, mit einem Gesamtmarktwert von $2,480,000 laut Einreichung, und das Unternehmen hat nach Angabe 50,237,647 ausstehende Aktien.
Die Einreichung verzeichnet au脽erdem einen fr眉heren Verkauf in den letzten drei Monaten: Christopher Peetz verkaufte 40.000 Aktien am 08/07/2025 蹿眉谤 $2,210,040. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen, und weist darauf hin, dass die Wertpapiere bei Erwerb in Bargeld bezahlt wurden.
- None.
- None.
Insights
TL;DR: Insider notice for 40,000 shares (~0.08% of outstanding) from an option exercise; transaction size appears modest relative to company equity.
The Form 144 documents a proposed sale of 40,000 common shares acquired on 08/11/2025 via a stock option exercise, to be brokered by Morgan Stanley Smith Barney. The filing lists an aggregate market value of $2,480,000 and total shares outstanding of 50,237,647. From a capital-markets perspective, this represents a small percentage of the company's float, limiting likely market impact. The disclosure of a prior 40,000-share sale on 08/07/2025 for $2,210,040 provides recent pricing context. The form鈥檚 attestation about no undisclosed material information is standard.
TL;DR: Routine insider sale notice; compliance with Rule 144 is documented and the filer affirms no undisclosed material information.
The submission is a standard Rule 144 notice disclosing an insider-related sale following a stock option exercise. It names the executing broker and records a recent related sale by Christopher Peetz. The form includes the required attestation regarding material nonpublic information and notes cash payment at acquisition. From a governance standpoint, the filing satisfies disclosure obligations; no governance irregularities are evident in the document itself.
Mirum Pharmaceuticals, Inc. (MIRM) ha depositato un Form 144 segnalando la proposta vendita di 40,000 azioni ordinarie acquisite mediante esercizio di opzioni su azioni il 08/11/2025. La vendita sar脿 eseguita tramite Morgan Stanley Smith Barney LLC con un valore di mercato complessivo di $2,480,000 secondo il deposito, e la societ脿 risulta avere 50,237,647 azioni in circolazione, come indicato.
Il deposito riporta anche una vendita precedente negli ultimi tre mesi: Christopher Peetz ha venduto 40,000 azioni il 08/07/2025 per $2,210,040. Il dichiarante certifica di non possedere informazioni materiali sfavorevoli non divulgate e specifica che i titoli sono stati pagati in contanti al momento dell'acquisizione.
Mirum Pharmaceuticals, Inc. (MIRM) present贸 un Form 144 informando la propuesta de venta de 40,000 acciones ordinarias adquiridas mediante ejercicio de opciones sobre acciones el 08/11/2025. La venta se realizar谩 a trav茅s de Morgan Stanley Smith Barney LLC con un valor de mercado agregado de $2,480,000 seg煤n la presentaci贸n, y la compa帽铆a tiene 50,237,647 acciones en circulaci贸n, como se indica.
La presentaci贸n tambi茅n registra una venta previa durante los 煤ltimos tres meses: Christopher Peetz 惫别苍诲颈贸 40,000 acciones el 08/07/2025 por $2,210,040. El declarante certifica que no posee informaci贸n adversa material no divulgada y se帽ala que los valores fueron pagados en efectivo en el momento de la adquisici贸n.
Mirum Pharmaceuticals, Inc. (MIRM)电� Form 144毳� 鞝滌稖頃橃棳 08/11/2025鞐� 欤检嫕毵れ垬靹犿儩甓� 頄夓偓搿� 旆摑頃� 40,000 氤错喌欤�鞚� 毵る弰毳� 鞝滌晥頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 毵る弰电� Morgan Stanley Smith Barney LLC毳� 韱淀暣 鞁ろ枆霅� 鞓堨爼鞚措┌, 鞝滌稖靹滌棎 霐半ゴ氅� 齑� 鞁滌灔臧�旃� $2,480,000鞚搓碃 須岇偓鞚� 氚滍枆欤检嫕靾樀鐢 50,237,647欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 鞝滌稖靹滌棎电� 歆�雮� 3臧滌洈 霃欖晥鞚� 鞚挫爠 毵る弰霃� 旮办灛霅橃柎 鞛堨姷雼堧嫟: Christopher Peetz电� 08/07/2025鞐� 40,000欤�毳� $2,210,040鞐� 毵る弰頄堨姷雼堧嫟. 鞝滌稖鞛惖鐢 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃橂┌, 旆摑 鞁� 歃濌秾鞚� 顺勱笀鞙茧 歆�旮夒悩鞐堧嫟瓿� 氇呾嫓頄堨姷雼堧嫟.
Mirum Pharmaceuticals, Inc. (MIRM) a d茅pos茅 un Form 144 signalant la proposition de vente de 40,000 actions ordinaires acquises par exercice d'options sur actions le 08/11/2025. La vente doit 锚tre ex茅cut茅e par Morgan Stanley Smith Barney LLC pour un valeur de march茅 agr茅g茅e de $2,480,000 d'apr猫s le d茅p么t, et la soci茅t茅 compte 50,237,647 actions en circulation, comme indiqu茅.
Le d茅p么t enregistre 茅galement une vente ant茅rieure au cours des trois derniers mois : Christopher Peetz a vendu 40,000 actions le 08/07/2025 pour $2,210,040. Le d茅clarant certifie qu'il ne dispose d'aucune information d茅favorable mat茅rielle non divulgu茅e et pr茅cise que les titres ont 茅t茅 pay茅s en 别蝉辫猫肠别蝉 lors de l'acquisition.
Mirum Pharmaceuticals, Inc. (MIRM) hat ein Form 144 eingereicht, in dem der geplante Verkauf von 40.000 Stammaktien gemeldet wird, die durch Aus眉bung von Aktienoptionen am 08/11/2025 erworben wurden. Der Verkauf soll 眉ber Morgan Stanley Smith Barney LLC ausgef眉hrt werden, mit einem Gesamtmarktwert von $2,480,000 laut Einreichung, und das Unternehmen hat nach Angabe 50,237,647 ausstehende Aktien.
Die Einreichung verzeichnet au脽erdem einen fr眉heren Verkauf in den letzten drei Monaten: Christopher Peetz verkaufte 40.000 Aktien am 08/07/2025 蹿眉谤 $2,210,040. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen, und weist darauf hin, dass die Wertpapiere bei Erwerb in Bargeld bezahlt wurden.
FAQ
What does the Mirum (MIRM) Form 144 report?
What is the aggregate market value and outstanding share count disclosed?
Was there any related sale in the past three months for MIRM?
How were the acquired shares paid for according to the filing?
Does the filer attest to possession of any undisclosed material information?
